HFG is found in 9 entries

HFG as free ligands, exist in 9 entries. Examples include 4HVC, 4K88, 4OLF

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo

Chemical Component Summary

Name 7-bromo-6-chloro-3-{3-[(2R,3S)-3-hydroxypiperidin-2-yl]-2-oxopropyl}quinazolin-4(3H)-one
Identifiers 7-bromanyl-6-chloranyl-3-[2-oxidanylidene-3-[(2R,3S)-3-oxidanylpiperidin-2-yl]propyl]quinazolin-4-one
Synonyms Halofuginone
Formula C16 H17 Br Cl N3 O3
Molecular Weight 414.68 g/mol
Type non-polymer
Isomeric SMILES O[C@H]1CCCN[C@@H]1CC(=O)Cn1cnc2cc(Br)c(Cl)cc2c1=O
InChI InChI=1S/C16H17BrClN3O3/c17-11-6-13-10(5-12(11)18)16(24)21(8-20-13)7-9(22)4-14-15(23)2-1-3-19-14/h5-6,8,14-15,19,23H,1-4,7H2/t14-,15+/m1/s1

Chemical Details

Formal Charge 0
Atom Count 41
Chiral Atom Count 2
Chiral Atoms C2' C39
Bond Count 43
Aromatic Bond Count 6

Drug Info: DrugBank

DrugBank ID DB04866   (Different stereochemistry)
Name Halofuginone
  • investigational
  • vet_approved
Description Halofuginone is a low molecular weight quinazolinone alkaloid, and a potent inhibitor of collagen alpha1(I) and matrix metalloproteinase 2 (MMP-2) gene expression. Halofuginone also effectively suppresses tumor progression and metastasis in mice. Collgard Biopharmaceuticals is developing halofuginone for the treatment of scleroderma and received orphan drug designation from the U.S. Food and Drug Administration in March, 2000.
Synonyms (+/-)-trans-7-bromo-6-chloro-3-(3-(3-hydroxy-2-piperidyl)-acetonyl)-4(3H)-quinazolinone
  • Halofuginone hydrobromide
  • Halofuginone lactate
Brand Names
  • Halocur
  • Stenorol
  • Tempostatin
Affected Organism
  • Humans and other mammals
  • Protozoa
Indication For the treatment of scleroderma, cancer, and restenosis.
Pharmacology Halofuginone, a fully synthetic small molecule, is a potent and selective regulator of stromal cell activation, cell migration and Collagen type I synthesis, a process that has been identified as a 'master switch' in the body's tissue repair process.
Mechanism of action Halofuginone is a potent inhibitor of collagen a1(I) and matrix metalloproteinase 2 (MMP-2) gene expression. Halofuginone also suppresses extracellular matrix deposition and cell proliferation. The profound antitumoral effect of halofuginone is attributed to its combined inhibition of the tumor stromal support, vascularization, invasiveness, and cell proliferation.
  • Angiogenesis Inhibitors
  • Angiogenesis Modulating Agents
  • Anti-Infective Agents
  • Antineoplastic Agents
  • Antiparasitic Agents
CAS number 55837-20-2
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID: 21059682